Literature DB >> 11344649

[Lipid disorders in liver diseases].

P Studeník1.   

Abstract

The liver is the main organ of cholesterol, triglyceride metabolism and lipoprotein synthesis. In diffuse parenchymatous diseases which lead to cirrhosis of the liver a decline of VLDL and HDL particles occurs, as well as a decline of apo-B, apo-E lipoprotein (a). In cholestatic diseases the levels of free cholesterol, phospholipids and sometimes also triglyceride levels rise, in the termonal stage they decline again. A specific marker of cholestasis is the presence of abnormal lipoprotein X, which is formed from non-esterified cholesterol and phsopholipids regurgitating from bile. Primary lipid disorders may then cause liver disease--steatosis. The main risk factors are hypertriglyceridaemias. In the pathogenesis of liver steatosis in particular an increased supply of fatty acids into the liver, is involved, as well as defects in the process of VLDL synthesis and triglyceride release from the liver into the circulation. Hypercholesterolaemia is not a risk factor of steatosis.

Entities:  

Mesh:

Year:  2000        PMID: 11344649

Source DB:  PubMed          Journal:  Vnitr Lek        ISSN: 0042-773X


  2 in total

1.  Grape seeds proanthocyanidin extract as a hepatic-reno-protective agent against gibberellic acid induced oxidative stress and cellular alterations.

Authors:  Hanaa A Hassan; Maisaa M Al-Rawi
Journal:  Cytotechnology       Date:  2012-11-08       Impact factor: 2.058

2.  The relationship between lipid profile and severity of liver damage in cirrhotic patients.

Authors:  Mohammad Reza Ghadir; Ali Akbar Riahin; Abbas Havaspour; Mehrdad Nooranipour; Abbas Ali Habibinejad
Journal:  Hepat Mon       Date:  2010-12-01       Impact factor: 0.660

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.